Overview
Specialty finance company providing secured debt to middle-market firms.
Founded
2004
Deals · 12mo
1
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Ossio | Feb 2026Led | $50 MDebt | |
Vero Biotech | Feb 2024Led | $65 MDebt | |
Amelia | Mar 2023Led | $175 MOther Equity | |
Vytalize Health | Feb 2023Led | $100 MOther Equity | |
Yieldstreet | Aug 2022Led | $400 MDebt | |
Exiger | Nov 2021Led | $70 MDebt | |
NationsBenefits | Aug 2021Participated | $170 MOther Equity | |
Empyr | Aug 2015Participated | $8 MOther Equity | |
Cytovance Biologics | Oct 2014Led | $20 MDebt | |
Ossio | Feb 2026Led | $50 MDebt | |
Vero Biotech | Feb 2024Led | $65 MDebt | |
Amelia | Mar 2023Led | $175 MOther Equity | |
Vytalize Health | Feb 2023Led | $100 MOther Equity | |
Yieldstreet | Aug 2022Led | $400 MDebt | |
Exiger | Nov 2021Led | $70 MDebt | |
NationsBenefits | Aug 2021Participated | $170 MOther Equity | |
Empyr | Aug 2015Participated | $8 MOther Equity | |
Cytovance Biologics | Oct 2014Led | $20 MDebt |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Other Equity | 2 | 2 |
| Debt | 5 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Oct '14 | 1 |
| Nov '14 | 0 |
| Dec '14 | 0 |
| Jan '15 | 0 |
| Feb '15 | 0 |
| Mar '15 | 0 |
| Apr '15 | 0 |
| May '15 | 0 |
| Jun '15 | 0 |
| Jul '15 | 0 |
| Aug '15 | 1 |
| Sep '15 | 0 |
| Oct '15 | 0 |
| Nov '15 | 0 |
| Dec '15 | 0 |
| Jan '16 | 0 |
| Feb '16 | 0 |
| Mar '16 | 0 |
| Apr '16 | 0 |
| May '16 | 0 |
| Jun '16 | 0 |
| Jul '16 | 0 |
| Aug '16 | 0 |
| Sep '16 | 0 |
| Oct '16 | 0 |
| Nov '16 | 0 |
| Dec '16 | 0 |
| Jan '17 | 0 |
| Feb '17 | 0 |
| Mar '17 | 0 |
| Apr '17 | 0 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 0 |
| Aug '17 | 0 |
| Sep '17 | 0 |
| Oct '17 | 0 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 1 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 1 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 1 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 1 |
| Mar '23 | 1 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 1 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 1 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 5 |
| Fintech | 3 |
| Enterprise Software | 2 |
| AI & Machine Learning | 2 |
| Networks, Cloud & Communication | 1 |
| Marketing & Advertising | 1 |
| Manufacturing | 1 |
| E-Commerce & Retail | 1 |
| Professional Services | 1 |
| Data, Analytics & IT | 1 |
| Transportation & Logistics | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 1 |
| $10M-$25M | 1 |
| $25M-$50M | 0 |
| $50M-$100M | 3 |
| $100M-$250M | 3 |
| $250M-$500M | 1 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 9 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Horizon Technology Finance | 2 |
| Aequitas Capital | 1 |
| Avalon Ventures | 1 |
| BuildGroup | 1 |
| Correlation Ventures | 1 |
| Denali Growth Partners | 1 |
| Enhanced Healthcare Partners | 1 |
| Moore Venture Partners | 1 |
| North Coast Ventures | 1 |
| Sigma Partners | 1 |
| Sysco Ventures | 1 |
| The Pritzker Organization | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 7 | 78% |
| Participating | 2 | 22% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 3 | 43% |
| Co-led | 4 | 57% |
Team
Managing Director
Co-head , Retail and Consumer Products
Managing Director - New York Group Head
Managing Director and Co-portfolio manager
Vice President, Opportunistic Credit
Managing Director, Chief Financial Officer - Investment Funds
Managing Director
Managing Director
Chairman & CEO
Managing Director - Healthcare
